Kumar Anil, Aronow Wilbert S, Vadnerkar Aniket, Sidhu Puneet, Mittal Sanjay, Kasliwal Ravi R, Trehan Naresh
Department of Medicine, Soundshore Medical Center, New Rochelle, NY, USA.
Am J Ther. 2009 Mar-Apr;16(2):116-8. doi: 10.1097/MJT.0b013e31814db0ba.
In a prospective study, enhanced external counterpulsation (EECP) was performed for 1 hour each day for 35 days in 47 patients, mean age 61 +/- 8 years, with prior coronary revascularization who had chronic refractory angina pectoris despite antianginal drugs and who were not candidates for further coronary revascularization. Compared with baseline values, EECP significantly improved anginal symptoms, dyspnea on exertion, and quality of life after 35 days of treatment (P < 0.001) and at 1-year follow up (P < 0.001). Compared with the baseline value of 653 +/- 249 feet, EECP significantly improved the 6-minute walking distance to 1025 +/- 234 feet after 35 days of treatment (P < 0.001) and to 1040 +/- 221 feet at 1-year follow up (P < 0.001). However, EECP did not significantly affect left ventricular ejection fraction, left ventricular end-diastolic and end-systolic dimensions, left ventricular end-diastolic and end-systolic volumes, E/A ratio, isovolumic relaxation time, and deceleration time measured by two2-dimensional and Doppler echocardiography.
在一项前瞻性研究中,对47例平均年龄为61±8岁、既往有冠状动脉血运重建史、尽管使用抗心绞痛药物仍患有慢性难治性心绞痛且不适合进一步进行冠状动脉血运重建的患者,每天进行1小时增强型体外反搏(EECP)治疗,共治疗35天。与基线值相比,EECP在治疗35天后(P<0.001)和1年随访时(P<0.001),显著改善了心绞痛症状、运动时呼吸困难和生活质量。与基线值653±249英尺相比,EECP在治疗35天后显著改善了6分钟步行距离至1025±234英尺(P<0.001),在1年随访时改善至1040±221英尺(P<0.001)。然而,EECP对通过二维和多普勒超声心动图测量的左心室射血分数、左心室舒张末期和收缩末期内径、左心室舒张末期和收缩末期容积、E/A比值、等容舒张时间和减速时间没有显著影响。